Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Regulación y derecho · 8/12/20171 min de lectura
Prospective Grant of Exclusive Patent License: N-Acetyl Mannosamine as a Therapeutic Agent
Traducción automática local · Idioma original de la fuente
Resumen
The National Human Genome Research Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to Leadiant Biosciences, Inc, located in Gaithersburg, Maryland, USA.
Idioma original de la fuente: Federal Register — All DocumentsAbrir el comunicado original →